cocaine has been researched along with acamprosate in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Litten, RZ | 1 |
Wickelgren, I | 1 |
McGeehan, AJ; Olive, MF | 2 |
Abarca, C; Albrecht, U; Depner, M; Holzberg, D; Lascorz, J; Lathrop, M; Magnone, MC; Matsuda, F; Pendyala, G; Sanchis-Segura, C; Schreiber, S; Schumann, G; Soyka, M; Spanagel, R; Zghoul, T | 1 |
Herzig, V; Schmidt, WJ | 1 |
Bonci, A; Bowers, MS; Chen, BT; Chou, JK; Gass, JT; Janak, PH; Olive, MF; Osborne, MP; See, RE | 1 |
Dackis, C; Kampman, KM; Lynch, KG; O'Brien, CP; Pettinati, HM; Sparkman, T | 1 |
Bühler, KM; Echeverry-Alzate, V; Giné, E; Gorriti, MÁ; Huertas, E; López-Moreno, JA; Olmos, P; Rodríguez de Fonseca, F; Santos, Á; Tuda-Arízcun, M | 1 |
1 trial(s) available for cocaine and acamprosate
Article | Year |
---|---|
A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence.
Topics: Acamprosate; Alcohol Deterrents; Central Nervous System Agents; Cocaine; Cocaine-Related Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Philadelphia; Pilot Projects; Taurine; Treatment Outcome | 2011 |
8 other study(ies) available for cocaine and acamprosate
Article | Year |
---|---|
International update: new findings on promising medications.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Clinical Trials as Topic; Cocaine; Comorbidity; Europe; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Taurine; United States | 1996 |
Teaching the brain to take drugs.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Behavior, Addictive; Brain; Cocaine; Cocaine-Related Disorders; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Rats; Receptors, Glutamate; Substance-Related Disorders; Synaptic Transmission; Taurine | 1998 |
The anti-relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphine.
Topics: Acamprosate; Alcohol Deterrents; Animals; Cocaine; Conditioning, Operant; Dose-Response Relationship, Drug; Ethanol; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Morphine; Secondary Prevention; Taurine | 2003 |
The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption.
Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Amino Acid Transport System X-AG; Animals; Biological Clocks; Cell Cycle Proteins; Cocaine; Cocaine-Related Disorders; Glutamic Acid; Humans; Mice; Nuclear Proteins; Period Circadian Proteins; Taurine; Time Factors; Transcription Factors | 2005 |
Repeated-testing of place preference expression for evaluation of anti-craving-drug effects.
Topics: Acamprosate; Alcohol Deterrents; Analgesics, Opioid; Anesthetics, Local; Animals; Behavior, Animal; Cocaine; Conditioning, Psychological; Drug Evaluation, Preclinical; Male; Morphine; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Taurine | 2005 |
Attenuation of cocaine-induced reinstatement of cocaine conditioned place preference by acamprosate.
Topics: Acamprosate; Animals; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Extinction, Psychological; GABA Modulators; Male; Mice; Mice, Inbred C57BL; Secondary Prevention; Taurine | 2006 |
Acamprosate attenuates cocaine- and cue-induced reinstatement of cocaine-seeking behavior in rats.
Topics: Acamprosate; Alcohol Deterrents; Animals; Behavior, Addictive; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Extinction, Psychological; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Recurrence; Self Administration; Taurine | 2007 |
Cocaine reverses the naltrexone-induced reduction in operant ethanol self-administration: the effects on immediate-early gene expression in the rat prefrontal cortex.
Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Animals; Carrier Proteins; Cocaine; Conditioning, Operant; Cyclooxygenase 2; Dose-Response Relationship, Drug; Gene Expression; Genes, fos; Genes, Immediate-Early; Homer Scaffolding Proteins; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Prefrontal Cortex; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Self Administration; Taurine | 2012 |